News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Mike Broadhurst joins Altasciences as general manager of preclinical safety testing operations
Broadhurst told us there are several things that he is looking forward to: “The first is that I get to work with experienced individuals to continue to develop preclinical services that support both small and large molecule drug development.”
Broadhurst said he is particularly excited about growing a preclinical business that offers “the unique opportunity for sponsors to take their drugs from discovery to preclinical to proof of concept.”
“Our goal is not to be the biggest CRO but to be the CRO that makes a difference for each of our clients, whether they are a virtual organization, a mid-size biotech, or a large pharma,” he said.